Herbal Based Polymeric Nanoparticles as a Therapeutic Remedy for Breast Cancer

Author(s):  
Mohd Mughees ◽  
Saima Wajid

Background: The currently available anti breast cancer agents as well as conventional drug delivery methods have some limitations. Objective: In view of these limitations, researchers used phytochemicals/herbal extracts as anti-breast cancer agents together with the polymeric nanoparticles to provide an effective way of targeted drug delivery with lesser /no side effects. Methods: The literature for this review was searched during the year 2014 to 2018 by using the keywords, ‘ ‘breast cancer’, ‘breast cancer and its current treatments’, ‘plants against the breast cancer’, ‘polymeric nanoparticles’, ‘herbal based polymeric nanoparticles’. The databases i.e. PubMed, Science Direct and Google Scholar were used for collecting the information. Results: In the present review, we try to summarize the potential of herbal based nanoformulation as specific and high efficacy therapeutic strategy in order to pave a way for the future research involving screening and use of herbal nanoparticles for the treatment of breast cancer. Conclusion: The encapsulation of the herbal extract in the polymeric nanoparticles is the prominent, effective and emerging way of targeted drug delivery for cancer. It may serve as safer way of targeted drug delivery and may be the answer of the complications related to the currently available anti-breast cancer agents as well as limitations of conventional method of drug delivery.

2019 ◽  
Vol 7 (39) ◽  
pp. 6048-6063 ◽  
Author(s):  
Mohd Mughees ◽  
Mohd Samim ◽  
Yadhu Sharma ◽  
Saima Wajid

The shortcomings of the currently available anti-breast cancer agents compel the development of the safer targeted drug delivery for the treatment of breast cancer.


2017 ◽  
Vol 9 (14) ◽  
pp. 12227-12240 ◽  
Author(s):  
Yu Zhang ◽  
Qin Guo ◽  
Sai An ◽  
Yifei Lu ◽  
Jianfeng Li ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (6) ◽  
pp. e66128 ◽  
Author(s):  
Ruei-Min Lu ◽  
Min-Shan Chen ◽  
De-Kuan Chang ◽  
Chien-Yu Chiu ◽  
Wei-Chuan Lin ◽  
...  

Biomaterials ◽  
2015 ◽  
Vol 59 ◽  
pp. 88-101 ◽  
Author(s):  
Arpan Satsangi ◽  
Sudipa S. Roy ◽  
Rajiv K. Satsangi ◽  
Anthony W. Tolcher ◽  
Ratna K. Vadlamudi ◽  
...  

Biomaterials ◽  
2009 ◽  
Vol 30 (5) ◽  
pp. 859-866 ◽  
Author(s):  
Yogesh B. Patil ◽  
Udaya S. Toti ◽  
Ayman Khdair ◽  
Linan Ma ◽  
Jayanth Panyam

2019 ◽  
Vol 12 (2) ◽  
pp. 83-95 ◽  
Author(s):  
A. V. Kuroyedov ◽  
V. V. Brzhesky ◽  
E. A. Krinitsyna

Ocular targeted drug delivery is one of the most challenging tasks for pharmaceutical researchers and practical ophthalmologists. The possibilities of drug delivery to the eye are naturally determined by the anatomical structure of the eye and its physiological properties, which restrict the period when therapeutically required drug concentration could be maintained. Combined drug delivery schemes may, potentially, improve the patient’s acceptance of treatment, reduce side effects, increase efficacy, and eventually preserve vision.


Author(s):  
Shyam Prasad ◽  
Vidhu Aeri ◽  
Yashwant .

The conventional drug delivery system for colonic disease may leads to absorption of drug across biological membrane of gastrointestinal tract (GIT). The absorption of drug throughout GIT may leads to increase in dose and associated side effects. Colon targeted drug delivery (CTDD) is a method of delivering medication to a patient in a manner that increases concentration of the medication in colon relative to other part of GIT. The aim of CTDD is to prolong, localize, target and have protected drug interaction to diseased tissue. The present review deals with primary as well as recent approaches of delivery of drug to colon.


Sign in / Sign up

Export Citation Format

Share Document